Latest Breaking News On - முதல் இணைப்பு - Page 6 : comparemela.com

On April 15, 2021, Relay Therapeutics, Inc. (the Company ) entered into an Agreement and Plan of Merger (the Merger Agreement ) by and among the Company, Elixir Merger Sub I, Inc., a Delaware corporation and a wholly-owned direct subsidiary of the Company ( First Merger Sub ), Elixir Merger Sub II, LLC, a Delaware limited liability company and a wholly-owned direct subsidiary of the Company ( Second Merger Sub and together with First Merger Sub, the Merger Subs ), ZebiAI Therapeutics, Inc., a Shareholder Representative Services LLC, a Colorado limited liability company, solely in its capacity as the representative of the ZebiAI Holders (as defined below). Subject to the satisfaction or waiver of the conditions set forth in the

United statesShareholder representative servicesCompany the surviving corporation first mergerCompany second merger subZebiai therapeutics incExchange commissionCompany annual report on formElixir merger subRelay therapeutics incElixir merger subi incCompany the second mergerSecurities exchangeCompany first merger subDefinitive materialFirst merger subMerger agreement